Past year
All results
- All results
- Verbatim
Oct 17, 2024 · This review summarizes disease risk stratification, treatment modalities, and outcomes for patients with MDS and related disorders, and discusses specific ...
Missing: Haematopoietic | Show results with:Haematopoietic
Jul 1, 2024 · Hematopoietic stem cell transplantation (HCT) is indicated for patients with higher-risk (HR) myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).
May 17, 2024 · The aim of our study was to investigate the key characteristics of Haplo family donors that could have an impact on transplant outcomes in patients with acute ...
May 30, 2024 · Prognostic impact of donor source on allogeneic hematopoietic stem cell transplantation outcomes in adults with chronic myelomonocytic leukemia.
Mar 6, 2024 · Hematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the ...
Mar 3, 2024 · The aim of our study was to investigate the key characteristics of Haplo family donors that could have an impact on transplant outcomes in patients with acute ...
Nov 20, 2024 · The EBMT will be actively participating in the 66th ASH Annual Meeting & Exposition that will take place December 7-10, 2024, in San Diego, California, ...
Missing: syndromes | Show results with:syndromes
Jan 30, 2024 · Patients age ≥70 years with acute myelogenous leukemia have a 2-year survival after hematopoietic stem cell transplantation of 38%. •. Patients with a Karnofsky ...
Missing: syndromes | Show results with:syndromes
Nov 13, 2024 · ... Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation in First Remission: On Behalf of the EBMT Acute Leukemia Working Party
May 9, 2024 · The use of HCT doubled in about a decade worldwide at different speed and with significant changes regarding donor match as a sign of improved access to HCT ...